참고문헌
- Alameda JP, Moreno-Maldonado R, Navarro M, et al (2010). An inactivating CYLD mutation promotes skin tumor progression by conferring enhanced proliferative, survival and angiogenic properties to epidermal cancer cells. Oncogene, 29, 6522-32. https://doi.org/10.1038/onc.2010.378
- Ambros V (2004). The functions of animal microRNAs. Nature, 431, 350-5. https://doi.org/10.1038/nature02871
- Andre T, Tuvignon N, Taieb J, et al (2010). Operable colon cancer: initial strategy. Rev Prat, 60, 1089-93.
- Aschele C, Bergamo F, Lonardi S (2009). Chemotherapy for operable and advanced colorectal cancer. Cancer Treat Rev, 35, 509-16. https://doi.org/10.1016/j.ctrv.2009.04.003
- Bartel DP (2004). MicroRNAs: genomics, biogenesis, mechanism, and function. Cell, 116, 281-97. https://doi.org/10.1016/S0092-8674(04)00045-5
- Calin GA, Croce CM (2006). MicroRNA signatures in human cancers. Nat Rev Cancer, 6, 857-66. https://doi.org/10.1038/nrc1997
- Chen P, Wang BL, Pan BS, et al (2014). MiR-1297 regulates the growth, migration and invasion of colorectal cancer cells by targeting cyclo-oxygenase-2. Asian Pac J Cancer Prev, 15, 9185-90. https://doi.org/10.7314/APJCP.2014.15.21.9185
- Esquela-Kerscher A, Slack FJ (2006). Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer, 6, 259-69. https://doi.org/10.1038/nrc1840
- Gao Y, Li BD, Liu YG (2013). Effect of miR27a on proliferation and invasion in colonic cancer cells. Asian Pac J Cancer Prev, 14, 4675-8. https://doi.org/10.7314/APJCP.2013.14.8.4675
- Iliopoulos D, Jaeger SA, Hirsch HA, et al (2010). STAT3 activation of miR-21 and miR-181b-1 via PTEN and CYLD are part of the epigenetic switch linking inflammation to cancer. Mol Cell, 39, 493-506. https://doi.org/10.1016/j.molcel.2010.07.023
- Jemal A, Bray F, Center MM, et al (2011). Global cancer statistics. CA Cancer J Clin, 61, 69-90. https://doi.org/10.3322/caac.20107
- Kinoshita H, Okabe H, Beppu T, et al (2013). CYLD downregulation is correlated with tumor development in patients with hepatocellular carcinoma. Mol Clin Oncol, 1, 309-14.
- Knudsen KE, Diehl JA, Haiman CA, et al (2006). Cyclin D1: polymorphism, aberrant splicing and cancer risk. Oncogene, 25, 1620-8. https://doi.org/10.1038/sj.onc.1209371
- Massoumi R, Chmielarska K, Hennecke K, et al (2006). Cyld inhibits tumor cell proliferation by blocking Bcl-3-dependent NF-kappaB signaling. Cell, 125, 665-77. https://doi.org/10.1016/j.cell.2006.03.041
- Miliani de Marval P, Lutfeali S, Jin JY, et al (2011). CYLD inhibits tumorigenesis and metastasis by blocking JNK/AP1 signaling at multiple levels. Cancer Prev Res, 4, 851-9. https://doi.org/10.1158/1940-6207.CAPR-10-0360
- Primrose JN (2010). Surgery for colorectal liver metastases. Br J Cancer, 102, 1313-8. https://doi.org/10.1038/sj.bjc.6605659
- Raman M, Ambalam P, Kondepudi KK, et al (2013). Potential of probiotics, prebiotics and synbiotics for management of colorectal cancer. Gut Microbes, 4, 181-92. https://doi.org/10.4161/gmic.23919
- Ratschiller D, Heighway J, Gugger M, et al (2003). Cyclin D1 overexpression in bronchial epithelia of patients with lung cancer is associated with smoking and predicts survival. J Clin Oncol, 21, 2085-93. https://doi.org/10.1200/JCO.2003.03.103
- Rico-Rosillo MG, Vega-Robledo GB, Oliva-Rico D (2014). The role and importance of the microRNAs in the diagnosis and development of diseases. Rev Med Inst Mex Seguro Soc, 52, 302-7.
- Roy AL, Carruthers C, Gutjahr T, et al (1993). Direct role for Myc in transcription initiation mediated by interactions with TFII-I. Nature, 365, 359-61. https://doi.org/10.1038/365359a0
- Sharma M, Sharma S, Arora M, et al (2013). Regulation of cellular Cyclin D1 gene by arsenic is mediated through miR-2909. Gene, 522, 60-4. https://doi.org/10.1016/j.gene.2013.03.058
- Shi L, Wang Z, Sun G, et al (2014). miR-145 inhibits migration and invasion of glioma stem cells by targeting ABCG2. Neuromolecular Med, 16, 517-28. https://doi.org/10.1007/s12017-014-8305-y
- Suppiah A, Hartley JE, Monson JR (2009). Advances in radiotherapy in operable rectal cancer. Dig Surg, 26, 187-99. https://doi.org/10.1159/000219931
- Xia JT, Chen LZ, Jian WH, et al (2014). MicroRNA-362 induces cell proliferation and apoptosis resistance in gastric cancer by activation of NF-kappaB signaling. J Transl Med, 12, 33. https://doi.org/10.1186/1479-5876-12-33
- Zhang L, Dong Y, Zhu N, et al (2014). microRNA-139-5p exerts tumor suppressor function by targeting NOTCH1 in colorectal cancer. Mol Cancer, 13, 124. https://doi.org/10.1186/1476-4598-13-124
- Zhong Q, Wang T, Lu P, et al (2014). miR-193b promotes cell proliferation by targeting Smad3 in human glioma. J Neurosci Res, 92, 619-26. https://doi.org/10.1002/jnr.23339
피인용 문헌
- Comparison of the miRNA profiles in HPV-positive and HPV-negative tonsillar tumors and a model system of human keratinocyte clones vol.16, pp.1, 2016, https://doi.org/10.1186/s12885-016-2430-y
- MiR-130b inhibits proliferation and induces apoptosis of gastric cancer cells via CYLD vol.37, pp.6, 2016, https://doi.org/10.1007/s13277-015-4632-3
- MicroRNA-454 may function as an oncogene via targeting AKT in triple negative breast cancer vol.24, pp.1, 2017, https://doi.org/10.1186/s40709-017-0067-x
- miR-922 regulates CYLD expression and promotes the cell proliferation of human hepatocellular carcinoma vol.37, pp.3, 2017, https://doi.org/10.3892/or.2017.5431
- miR-130b regulates the proliferation, invasion and apoptosis of glioma cells via targeting of CYLD vol.38, pp.1, 2017, https://doi.org/10.3892/or.2017.5651
- MicroRNAs in the prognosis of triple-negative breast cancer vol.96, pp.22, 2017, https://doi.org/10.1097/MD.0000000000007085
- MicroRNA-454 inhibits tumor cell proliferation, migration and invasion by downregulating zinc finger E-box-binding homeobox 1 in gastric cancer vol.16, pp.6, 2017, https://doi.org/10.3892/mmr.2017.7758